Under construction – not a live service
Sign in
Taking people in AustraliaNo phase

Post Market Clinical Follow up of ResMed Mask Systems

Key facts

Who runs it
ResMed
Where
Sydney, AustraliaSee the site
Trial code
Status
Recruiting
People taking part
500 people, planned
Started
26 May 2022
Expected to end
Jun 2027
Type of study
Interventional
Treatments tested
  • New generation CPAP mask
Record updated
29 April 2026

Who can take part

Age
18 years to 100 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Participants willing to give written informed consent
  • Participants who can read and comprehend English
  • Participants who ≥ 18 years of age
  • Participants being treated for OSA for ≥ 6 months
  • Participants currently using a suitable mask system
  • Participants currently using CPAP device compatible with AirView, or with download capacity from CPAP machine from data cards

Who cannot take part

  • Participants who or whose bed partner has implantable metallic implants in the head, neck and chest region affected by magnetic fields (Non-ferrous implants may be acceptable) (for masks with magnetic clips only)
  • Participants with a pre-existing lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (< 2years) case of pneumonia or lung infection; lung injury
  • Participants using Bilevel flow generators
  • Participants who are or may be pregnant
  • Participants believed to be unsuitable for inclusion by the researcher

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 100 years old?

Where in Australia

  • Medical Affairs ResMedSydney, AustraliaContact: Jeff Armitstead, PhDTaking people

About the trial

What the trial wants to find out

Post Market follow up study to systematically and proactively collect supplementary real world data to confirm the usability and performance of the new generation mask systems. .

The group in the trial

  • New generation CPAP maskTreatment being tested

    The intended purpose of mask systems is to provide airflow from a CPAP device, through tubing, and to the patient. The air acts as a pneumatic splint to keep the airway open and prevent collapse during sleep. The masks to be used in this study are released masks approved and released.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Fit questions
Built from NCT05262439, who can take part
Record updated
29 April 2026